The University of Wisconsin Comprehensive Cancer Center (UWCCC) was established in 1973 as a comprehensive, matrix center. By fostering and coordinating cancer research, it plays a leading role in the Medical School, on campus and in the region. Its 167 members, from 38 departments and eight different University schools participate in nine research programs: Breast Cancer, Urologic Cancer, Cell Adhesion and Signaling, Ocular Tumors, Immunology and Biological Therapeutics, Radiation Oncology and Physics, Developmental Therapeutics, Pediatric Oncology and Cancer Control. These programs encompass laboratory, clinical and population- based research and emphasize translation. Members have explored in laboratory and clinic the use and mechanisms of such anti-cancer agents as fluorouracil, perillyl alcohol, interferon, interleukin 2, monoclonal antibodies, tamoxifen and difluoromethylornithine. They have made fundamental discoveries about bladder, colon, and breast cancer etiology and the mechanisms of malignant transformation. Members' pain control projects have lead to cancer pain initiatives now located in every state and impacting internationally. Epidemiologic studies of women in Wisconsin have revealed modifiable factors that may decrease the risk of breast and bowel cancers. UWCCC has created a supportive environment for new and established investigators. Nine shared resources and the center's space, computing infrastructure, and common equipment serve members effectively. Biostatistics and the Clinical Trials Research Office are model shared resource. Flow Cytometry, the Analytical Laboratory, the Transgenic Animal and Scientific Instrumentation Facilities benefit many programs and projects. The present application, under new UWCCC Director John E. Niederhuber, M.D., requests renewal of comprehensive status and three years of support for key leaders, staff investigators, shared resources, and planning and evaluation. It describes the planned merger with McArdle Laboratory for Cancer Research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-26
Application #
2558456
Study Section
Subcommittee G - Education (NCI)
Program Officer
Mccormick, Patricia
Project Start
1976-01-01
Project End
2001-03-31
Budget Start
1998-06-24
Budget End
1999-03-31
Support Year
26
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Schumacher, Jessica R; Neuman, Heather B; Chang, George J et al. (2018) A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol 25:2587-2595
Turk, Anita A; Wisinski, Kari B (2018) PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside. Cancer 124:2498-2506
Liu, Ting; Shi, Changzheng; Duan, Linqi et al. (2018) A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis. J Mater Chem B 6:4756-4764
Zhan, Yonghua; Ehlerding, Emily B; Shi, Sixiang et al. (2018) Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging. J Biomed Nanotechnol 14:900-909
Bloom, Debra D; Reshetylo, Sofiya; Nytes, Cassandra et al. (2018) Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother 41:213-223
Wei, Weijun; Jiang, Dawei; Ehlerding, Emily B et al. (2018) Noninvasive PET Imaging of T cells. Trends Cancer 4:359-373
Fricke, Stephanie L; Payne, Susan N; Favreau, Peter F et al. (2018) MTORC1/2 inhibition as a therapeutic strategy for PIK3CA mutant cancers. Mol Cancer Ther :
Feld, Shara I; Fan, Jun; Yuan, Ming et al. (2018) Utility of Genetic Testing in Addition to Mammography for Determining Risk of Breast Cancer Depends on Patient Age. AMIA Jt Summits Transl Sci Proc 2017:81-90
Hernández-Santos, Nydiaris; Wiesner, Darin L; Fites, J Scott et al. (2018) Lung Epithelial Cells Coordinate Innate Lymphocytes and Immunity against Pulmonary Fungal Infection. Cell Host Microbe 23:511-522.e5
van Ravesteyn, Nicolien T; van den Broek, Jeroen J; Li, Xiaoxue et al. (2018) Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches. Med Decis Making 38:126S-139S

Showing the most recent 10 out of 1528 publications